Nathan Smith | Senior Vice President, Investor Relations |
Paul Diaz | President & Chief Executive Officer |
Bryan Riggsbee | Chief Financial Officer |
Nicole Lambert | Chief Operating Officer |
Jack Meehan | Nephron Research |
Kyle Boucher | Cowen |
Greetings and welcome to the Myriad Genetics First Quarter 2022 Financial Earnings Call.
During the presentation, all participants will be in a listen-only mode. Afterwards we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today Thursday, May 5 2022. I'd now like to turn the call over to Nathan Smith, Senior Vice President of Investor Relations.